Danilo Maddalo

11PUBLICATIONS
131CO-AUTHORS
Biologically active moleculesMolecular targetsCancer cell biologyAutomated software engineering
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jun 27, 2026
Covalent pan-TEAD inhibitors block YAP activity and demonstrate brain penetrance in a Hippo-dependent cancer model.

|Mar 05, 2026
The Hippo Pathway Is Dysregulated in Cancer-Associated Fibroblasts in Anti-PD-L1-Resistant Cancer.

Juliette Roels, Hamid Ghaedi, Jayaram Kancherla

|Oct 27, 2025
PI3Kα Inhibitor and Degrader Inavolisib Can Co-opt FGFR2 to Enhance Responses in Patients with PIK3CA-Mutated Solid Tumors and in Preclinical Models.

Dejan Juric, Kyung Song, Radia M Johnson

|Jul 08, 2025
KRAS Codon-Specific Mutations Differentially Toggle PI3K Pathway Signaling and Alter Sensitivity to Inavolisib (GDC-0077).

Kyung W Song, Christy C Ong, Eva Lin

|Jul 03, 2025
RIT1M90I Is a Driver of Lung Adenocarcinoma Tumorigenesis and Resistance to Targeted Therapy.

Ashley V DiMarco, Mirunalini Ravichandran, Jeff Lau

|Sep 08, 2023
SHP2: A Pleiotropic Target at the Interface of Cancer and Its Microenvironment.

Nicole M Sodir, Gaurav Pathria, Joanne I Adamkewicz

Pageof 2

Frequent Collaborators

4 joint publications

Nicole M Sodir

3 joint publications

Eva Lin

3 joint publications

Anwesha Dey

3 joint publications

Jeffrey T Lau